UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 457

Sortiert nach

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

International journal of clinical practice (Esher), 2010-04, Vol.64 (5), p.562-576

2010

Volltextzugriff (PDF)

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

International Journal of Obesity, 2010-05, Vol.34 (5), p.919-935

2010

Volltextzugriff (PDF)

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

International Journal of Obesity, 2010-08, Vol.34 (8), p.1243-1254

2010

Volltextzugriff (PDF)

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Diabetes, obesity & metabolism, 2013-12, Vol.15 (12), p.1101-1110

2013

Volltextzugriff (PDF)

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-02, Vol.65 (2), p.154-164

2011

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-09, Vol.65 (9), p.930-938

2011

Volltextzugriff (PDF)

Finasteride increases anagen hair in men with androgenetic alopecia

British journal of dermatology (1951), 2000-10, Vol.143 (4), p.804-810

2000

Volltextzugriff (PDF)

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-03, Vol.12 (3), p.252-261

2010

Volltextzugriff (PDF)

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.498-504

2011

Volltextzugriff (PDF)

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.644-652

2011

Volltextzugriff (PDF)

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Dermatologic surgery, 1998-12, Vol.24 (12), p.1330-1332

1998

Volltextzugriff (PDF)

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Diabetes, obesity & metabolism, 2014-03, Vol.16 (3), p.223-230

2014

Volltextzugriff (PDF)

Androgen metabolism as it affects hair growth in androgenetic alopecia

Dermatologic clinics, 1996-10, Vol.14 (4), p.697

Kaufman, K D

1996

Volltextzugriff (PDF)

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.841-849

2011

Volltextzugriff (PDF)

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-05, Vol.14 (5), p.409-418

2012

Volltextzugriff (PDF)

Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men

The Journal of urology, 1999-10, Vol.162 (4), p.1295

1999

Volltextzugriff (PDF)

one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-06, Vol.12 (6), p.517-531

2010

Volltextzugriff (PDF)

Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes

Current medical research and opinion, 2015-06, Vol.31 (6), p.1071-1077

2015

Volltextzugriff (PDF)

Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement

Current medical research and opinion, 2009-10, Vol.25 (10), p.2507-2514

2009

Volltextzugriff (PDF)

Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1 mg Treatment of Men and Postmenopausal Women

The Journal of investigative dermatology symposium proceedings, 1999-12, Vol.4 (3), p.282-284

1999

Volltextzugriff (PDF)

How lupoid is lupoid hepatitis?

Journal of rheumatology, 1986-02, Vol.13 (1), p.95

1986

Volltextzugriff (PDF)

Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia

EJD. European journal of dermatology, 2002, Vol.12 (1), p.38-49

Finasteride Male Pattern Hair Loss Study Group

2002

Volltextzugriff (PDF)

Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results

Journal of the American Academy of Dermatology, 2006-07, Vol.55 (1), p.71-74

2006

Volltextzugriff (PDF)

Neurological complications of peripheral and cutaneous T-cell lymphomas

Annals of neurology, 1994-10, Vol.36 (4), p.625-629

1994

Volltextzugriff (PDF)

Frequency and significance of antibody to double‐stranded DNA in chronic active hepatitis

Hepatology (Baltimore, Md.), 1986-09, Vol.6 (5), p.976-980

1986

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(426)
Mit Volltextzugriff
(366)

Publikationsform

Artikel
(456)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

Finasteride increases anagen hair in men with androgenetic alopecia

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Androgen metabolism as it affects hair growth in androgenetic alopecia

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men

one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes

Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement

Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1 mg Treatment of Men and Postmenopausal Women

How lupoid is lupoid hepatitis?

Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia

Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results

Neurological complications of peripheral and cutaneous T-cell lymphomas

Frequency and significance of antibody to double‐stranded DNA in chronic active hepatitis

Aktive Filter

Suchergebnisse filtern